Related references
Note: Only part of the references are listed.Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
P. M. Forde et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer
S. J. Antonia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE)
Wilfried Ernst Erich Eberhardt et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Comparative effectiveness of neoadjuvant chemoradiotherapy versus chemotherapy alone followed by surgery for patients with stage IIIA non-small cell lung cancer
David J. Sher et al.
LUNG CANCER (2015)
Treatment of Stage III Non-small Cell Lung Cancer Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Nithya Ramnath et al.
CHEST (2013)
Treatment of Stage I and II Non-small Cell Lung Cancer Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
John A. Howington et al.
CHEST (2013)
Radiation Therapy Oncology Group Protocol 02-29: A Phase II Trial of Neoadjuvant Therapy With Concurrent Chemotherapy and Full-Dose Radiation Therapy Followed by Surgical Resection and Consolidative Therapy for Locally Advanced Non-small Cell Carcinoma of the Lung
Mohan Suntharalingam et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Surgical Outcome of Stage IIIA-cN2/pN2 Non-Small-Cell Lung Cancer Patients in Japanese Lung Cancer Registry Study in 2004
Ichiro Yoshino et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Phase II Trial of a Trimodality Regimen for Stage III Non-Small-Cell Lung Cancer Using Chemotherapy As Induction Treatment With Concurrent Hyperfractionated Chemoradiation With Carboplatin and Paclitaxel Followed by Subsequent Resection: A Single-Center Study
Godehard Friedel et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial
Kathy S. Albain et al.
LANCET (2009)
Lung Adjuvant Cisplatin Evaluation: A pooled analysis by the LACE collaborative group
Jean-Pierre Pignon et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non-Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups
Gary M. Strauss et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Effect of preoperative chemoradiation in addition to preoperative chemotherapy:: a randomised trial in stage III non-small-cell lung cancer
Michael Thomas et al.
LANCET ONCOLOGY (2008)
A phase II study of concurrent carboplatin and paclitaxel and thoracic radiotherapy for completely resected stage II and IIIA non-small cell lung cancer
Steven J. Feigenberg et al.
JOURNAL OF THORACIC ONCOLOGY (2007)
Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer
Jan P. van Meerbeeck et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
A phase III study of surgical resection and paclitaxel/carboplatin chemotherapy with or without adjuvant radiation therapy for resected stage III non-small cell lung cancer: cancer and leukemia group B 9734
Michael C. Perry et al.
CLINICAL LUNG CANCER (2007)
Nodal downstaging predicts survival following induction chemotherapy for stage IIIA (N2) non-small cell lung cancer in CALGB protocol #8935
Michael T. Jaklitsch et al.
JOURNAL OF SURGICAL ONCOLOGY (2006)
Postoperative radiotherapy for stage II or III non-small-cell lung cancer using th surveillance, epidemiology, and end results database
Brian E. Lally et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial
Jean-Yves Douillard et al.
LANCET ONCOLOGY (2006)
Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer
T Winton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Mediastinal lymph node clearance after docetaxel-cisplatin Neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer:: A multicenter phase II trial
DC Betticher et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival
R Bueno et al.
ANNALS OF THORACIC SURGERY (2000)
Share Paper
